PharVision Advisers’s StubHub Holdings STUB Stock Holding History

PharVision Advisers’s Portfolio STUB Stock Details STUB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$99.2K	Buy	+17,769	New	+$141K	4.02%	7

Other funds holding STUB

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Stephens Group Little Rock, Arkansas $204M AUM 38.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

RCP

RPM Capital Partners New York $18.1M AUM 30.1% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Ahara Advisors Jersey City, New Jersey $165M AUM 22.09% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

PharVision Advisers's STUB Position: Q3 2026 in Review

PharVision Advisers opened a new position in StubHub Holdings (STUB) in Q3 2026: 17,769 shares worth $99.2K. The stake represents 4.02% of the portfolio and ranks #7 among its holdings.

72 funds tracked by Wall St. Rank hold STUB as of Q3 2026.

PharVision Advisers held 17,769 shares of StubHub Holdings worth $99.2K as of Q3 2026.
StubHub Holdings was a new PharVision Advisers position in Q3 2026.
StubHub Holdings made up 4.02% of PharVision Advisers's portfolio in Q3 2026, its #7 holding.
72 funds tracked by Wall St. Rank held StubHub Holdings as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.